eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | multiple myeloma |
| Symptom | C0032131|plasmacytomas |
| Sentences | 8 |
| PubMedID- 22105527 | Incidence of plasmacytomas associated with multiple myeloma range from 7% to 17% at diagnosis and from 6% to 20% during the course of the disease. |
| PubMedID- 25694834 | A final diagnosis of multiple myeloma complicated with extramedullary plasmacytomas involving the pancreas, suprarenal gland, kidney, skin, lung, liver, spleen, and lymph nodes was attained. |
| PubMedID- 24986687 | Our results for plasmacytomas highlight the significance of antiapoptotic changes in multiple myeloma, which include elevated expression of mcl-1 and, less frequently, bcl-2, and suggest that closer attention to defects in bim expression is warranted. |
| PubMedID- 21900099 | Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach. |
| PubMedID- 23326271 | Recurrent plasmacytomas after allografting in a patient with multiple myeloma. |
| PubMedID- 20944171 | Background: a case of relapsed multiple myeloma (mm) with multiple plasmacytomas of the parietal bone and the right orbit in which was achieved a complete response with bortezomib plus dexamethasone (bd) therapy is reported. |
| PubMedID- 22781459 | Objective: to explore the clinical features, treatment and prognosis of multiple myeloma (mm) with extramedullary plasmacytomas (em). |
| PubMedID- 22738942 | No clinical, laboratory, or imaging findings indicative of multiple myeloma or association with other plasmacytomas were found, so the tumor was considered to be a primary pancreatic plasmacytoma. |
Page: 1